David Claxton is an Oncology physician affiliated with Pennsylvania State University. OpenAlex indexes 359 publications with 14,945 citations (h-index 52); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 University Dr
Hershey, PA 17033
Telephone
717-531-6585Registry record last updated 17 Jul 2018.
Clinical trials
- Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias
Sponsor: Milton S. Hershey Medical Center
- JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia
Sponsor: Milton S. Hershey Medical Center
- Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
Sponsor: Milton S. Hershey Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Servier Pharmaceuticals LLCProgram year20214 payments
- Kite Pharma, Inc.Program year20213 payments
- Astellas Pharma US IncProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30.2%Kinase inhibitor30.2%Sprycel54%Tasigna46%Part D<11 patientsCardiovascular
15.1%Antiarrhythmic15.1%Lidocaine100%Part D<11 patientsMetabolism & gastrointestinal
14%Proton pump inhibitor14%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2009–2014 per NIH RePORTER. The latest:
- Animal Modeling and Clinical Resources Core
Pennsylvania State Univ Hershey Med Ctr
FY2014$339,719P01CA171983 - Animal Modeling and Clinical Resources Core
Pennsylvania State Univ Hershey Med Ctr
FY2013$350,227P01CA171983 - CLINICAL TRIAL: PI TRIAL OF IMMUNOSTIMULATION JVRS-100 FOR RELAPSED OR REFRACTOR
Pennsylvania State Univ Hershey Med Ctr
FY2009$4,160M01RR010732
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramin Zand, MD, MPH
Pennsylvania State University
Allan Lipton, MD
Pennsylvania State University
Steven Ettinger, MD
Pennsylvania State University
Gerald Naccarelli, MD
Pennsylvania State University
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”